Luna Minute

Engineered receptors for soluble cellular communication and disease sensing

Platelet factor 4–induced T _H 1-T _reg polarization suppresses antitumor immunity

The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies

Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?

Hallmarks of aging: An expanding universe

COVID-19: A promising cure for the global panic

Delivery technologies for cancer immunotherapy

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments

Inflammation and tumor progression: signaling pathways and targeted intervention

Myeloid immunosuppression and immune checkpoints in the tumor microenvironment

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth

Complement in cancer: untangling an intricate relationship

Immunogenic cell stress and death

Cytokines in clinical cancer immunotherapy

The double-edged sword: Harnessing PD-1 blockade in tumor and autoimmunity

Diversity, Mechanisms, and Significance of Macrophage Plasticity

The Tumor Microenvironment Innately Modulates Cancer Progression

Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering

Pharmacological blockade of TNFα prevents sarcopenia and prolongs survival in aging mice

Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy

Antibody‐dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells

Innate immune mediators in cancer: between defense and resistance

Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15

Cellular cytotoxicity is a form of immunogenic cell death